Cite
MLA Citation
Giandomenico Roviello et al.. “Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?.” Therapeutic advances in urology, vol. 13, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100138933554.0x000048